Since 2001, hundreds of new companies have been set up based on research from the universities in the MICRA partnership. This has created thousands of jobs and attracted many millions of pounds in investment.
A key part of the MICRA programme is to continue this important work by supporting research projects to a stage where they have an investment-ready product or service to offer. Alongside this we are showcasing the companies in a series of events and activities to offer investors and commercial partners the opportunity to get involved with some of the most exciting developments to come out of the UK today.
A selection of our spin-out companies is shown below. To find out more, click on the profiles below to visit their website, or get in touch with us.
Please also read the Important Information at the foot of this page.
Our Spin Outs.
- AI & Data
- Energy & Environment
- Engineering, Materials & Manufacturing
- Medtech & Diagnostics
Opportunities for Investment and Partnerships.
The MICRA universities generate more patents per unit of research income than any other major UK university grouping. Our 100+ active spinouts, built from a collective annual investment in research of £550m, form the core of a regional pipeline of over 2,000 connected start-ups and affiliated businesses.
The paper value of the Midlands Innovation spinout portfolio alone is £560m. The universities’ interests have generated £15m in cash returns in the past five years. There is a high demand for capital. The spinouts already raise a collective average of over £60m investment a year. They are currently seeking around £105m.
Make An Enquiry.
The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Midlands Innovation Commercialisation of Research Accelerator (MICRA) does not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.